LCN2 and acute kidney injury: Several novel AKI biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), liver fatty acid-binding protein (L-FABP), and kidney injury molecule-1 (KIM-1) have been proposed; however, all of these possess important limitations [4,5].